The global healthcare company Abbott and the National Association of Community Health Centers (NACHC) have joined together to increase access to healthy foods and improve...
Abbott, announced data from late-breaking presentations showing the impact of its minimally invasive heart devices in treating mitral and tricuspid valve disease. Data include findings...
Abbott announces the launch of its TactiFlex, Sensor Enabled ablation catheter, the world's first ablation catheter with a flexible tip and contact force technology....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back...
Abbott announced late-breaking data for MitraClip, the leading therapy to treat leaky valves in people with mitral regurgitation (MR), that demonstrate long-term benefits of...
